S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NASDAQ:VRSN

VeriSign (VRSN) Stock Price, News & Analysis

$189.10
+2.00 (+1.07%)
(As of 03/27/2024 ET)
Today's Range
$187.74
$189.74
50-Day Range
$187.10
$206.35
52-Week Range
$185.19
$229.72
Volume
491,469 shs
Average Volume
581,946 shs
Market Capitalization
$19.08 billion
P/E Ratio
23.88
Dividend Yield
N/A
Price Target
$241.00

VeriSign MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
27.4% Upside
$241.00 Price Target
Short Interest
Healthy
1.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
0.53mentions of VeriSign in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$4.43 M Sold Last Quarter
Proj. Earnings Growth
7.93%
From $7.82 to $8.44 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.71 out of 5 stars

Computer And Technology Sector

62nd out of 589 stocks

Custom Computer Programming Services Industry

6th out of 26 stocks

VRSN stock logo

About VeriSign Stock (NASDAQ:VRSN)

VeriSign, Inc., together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. The company enables the security, stability, and resiliency of internet infrastructure and services, including providing root zone maintainer services, operating two of thirteen internet root servers; and offering registration services and authoritative resolution for the .com and .net domains, which supports global e-commerce. It operates directory for .name and .cc; and back-end systems for .edu, domain names. VeriSign, Inc. was incorporated in 1995 and is headquartered in Reston, Virginia.

VRSN Stock Price History

VRSN Stock News Headlines

VeriSign (NASDAQ:VRSN) Hits New 1-Year Low at $188.36
Verisign: Smaller Player With No Discount
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
VeriSign (NASDAQ:VRSN) Upgraded at StockNews.com
VRSN Apr 2024 195.000 call
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
VeriSign Stock (NASDAQ:VRSN) Insider Trades
VeriSign, Inc.
VRSN Mar 2024 200.000 call
VRSN Mar 2024 210.000 call
VRSN Jun 2024 155.000 put
VRSN Apr 2024 190.000 call
VRSN Mar 2024 100.000 put
Decoding VeriSign Inc (VRSN): A Strategic SWOT Insight
VeriSign Full Year 2023 Earnings: EPS Beats Expectations
VeriSign price target lowered by $1 at Citi, here's why
Q4 2023 Verisign Inc Earnings Call
See More Headlines
Receive VRSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VeriSign and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
3/28/2024
Next Earnings (Estimated)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Custom computer programming services
Sub-Industry
Internet Software & Services
Current Symbol
NASDAQ:VRSN
CUSIP
92343E10
Employees
907
Year Founded
1995

Price Target and Rating

Average Stock Price Target
$241.00
High Stock Price Target
$245.00
Low Stock Price Target
$237.00
Potential Upside/Downside
+27.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$817.60 million
Pretax Margin
65.40%

Debt

Sales & Book Value

Annual Sales
$1.49 billion
Cash Flow
$7.57 per share
Book Value
($15.48) per share

Miscellaneous

Free Float
99,952,000
Market Cap
$19.08 billion
Optionable
Optionable
Beta
0.88

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Should I Buy VeriSign Stock? VRSN Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of VeriSign was last updated on Monday, March 25, 2024 at 11:57 PM.

Pros

Here are some ways that investors could benefit from investing in VeriSign, Inc.:

  • VeriSign, Inc. provides domain name registry services and internet infrastructure that enable internet navigation for recognized domain names worldwide, supporting global e-commerce.
  • The company ensures the security, stability, and resiliency of internet infrastructure and services, including operating two of thirteen internet root servers.
  • Recent insider transactions indicate confidence in the company, with executives purchasing and holding significant shares.
  • VeriSign's stock price has shown consistent growth over the past year, indicating positive investor sentiment and potential for further appreciation.
  • The company's focus on internet software & services within the custom computer programming services industry positions it well for future growth and innovation.

Cons

Investors should be bearish about investing in VeriSign, Inc. for these reasons:

  • Market volatility and regulatory changes in the internet services sector could impact VeriSign's operations and financial performance.
  • Competition in the domain name registry services industry is intense, leading to potential pricing pressures and market share challenges for VeriSign.
  • Dependency on maintaining the security and stability of internet infrastructure exposes the company to cybersecurity risks and potential disruptions.
  • Changes in consumer behavior and technology trends could impact the demand for domain name registry services, affecting VeriSign's revenue growth.
  • High institutional ownership of VeriSign's stock may limit potential upside as large investors may influence stock price movements.

VRSN Stock Analysis - Frequently Asked Questions

Should I buy or sell VeriSign stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for VeriSign in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VRSN shares.
View VRSN analyst ratings
or view top-rated stocks.

What is VeriSign's stock price target for 2024?

2 equities research analysts have issued 1 year target prices for VeriSign's shares. Their VRSN share price targets range from $237.00 to $245.00. On average, they expect the company's stock price to reach $241.00 in the next twelve months. This suggests a possible upside of 27.4% from the stock's current price.
View analysts price targets for VRSN
or view top-rated stocks among Wall Street analysts.

How have VRSN shares performed in 2024?

VeriSign's stock was trading at $205.96 at the beginning of the year. Since then, VRSN stock has decreased by 8.2% and is now trading at $189.10.
View the best growth stocks for 2024 here
.

When is VeriSign's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our VRSN earnings forecast
.

How were VeriSign's earnings last quarter?

VeriSign, Inc. (NASDAQ:VRSN) announced its quarterly earnings data on Thursday, February, 8th. The information services provider reported $1.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.83 by $0.09. The information services provider had revenue of $380.40 million for the quarter, compared to analysts' expectations of $381.01 million. VeriSign had a negative trailing twelve-month return on equity of 46.56% and a net margin of 54.74%.

What guidance has VeriSign issued on next quarter's earnings?

VeriSign updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.6 billion-$1.6 billion, compared to the consensus revenue estimate of $1.6 billion.

What is D. James Bidzos' approval rating as VeriSign's CEO?

114 employees have rated VeriSign Chief Executive Officer D. James Bidzos on Glassdoor.com. D. James Bidzos has an approval rating of 76% among the company's employees.

What other stocks do shareholders of VeriSign own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VeriSign investors own include NVIDIA (NVDA), Home Depot (HD), Netflix (NFLX), Intel (INTC), Costco Wholesale (COST), Micron Technology (MU), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Boeing (BA).

Who are VeriSign's major shareholders?

VeriSign's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.23%), Vanguard Group Inc. (10.11%), Ninety One UK Ltd (5.13%), Principal Financial Group Inc. (2.33%), Cantillon Capital Management LLC (1.71%) and Norges Bank (0.99%). Insiders that own company stock include D James Bidzos, Danny R Mcpherson, George E Kilguss III, Kathleen A Cote, Medpace Investors, Llc, Thomas C Indelicarto, Thomas F Frist III, Timothy Tomlinson, Todd B Strubbe and Todd B Strubbe.
View institutional ownership trends
.

How do I buy shares of VeriSign?

Shares of VRSN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does VeriSign have any subsidiaries?
The following companies are subsidiares of VeriSign: 1 Global Place, 3united AG, CallVision, Geotrust Europe, H.O. Systems, Illuminet Holdings, Jamba, Kollective Technology, Moreover, Moreover Technologies, Network solution, Signio, SiteRock K.K., Thawte Consulting, UNC-Embratel, Unimobile Inc, inCode Wireless, and m-Qube.
Read More
This page (NASDAQ:VRSN) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners